SCOPUS 정보 검색 플랫폼

Biochemical and Biophysical Research Communications

Volumn 440, Issue 4, 2013, Pages 792-797

SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition

(6) Miao, Liyun a Wang, Yongsheng a Xia, Hongping b Yao, Chengyun c Cai, Hourong a Song, Yong a

a MEDICAL SCHOOL OF NANJING UNIVERSITY (China)

b DIVISION OF MEDICAL ONCOLOGY (Singapore)

c NANJING MEDICAL UNIVERSITY (China)

Author keywords

Epithelial mesenchymal transition; Lung cancer; SPOCK1; Transforming growth factor

Indexed keywords

MESSENGER RNA; OSTEONECTIN; RIBONUCLEASE; SMALL INTERFERING RNA; SPOCK1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FOLLOW UP; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LOBECTOMY; LUNG ALVEOLUS CELL; LUNG CANCER; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84887028298 PISSN: 0006291X EISSN: 10902104 Source Type: Journal
DOI: 10.1016/j.bbrc.2013.10.024 Document Type: Article

Times cited : (65)

References (16)

1
- 79952232216
- Global cancer statistics
- A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
- (2011) CA Cancer J. Clin. , vol.61 , pp. 69-90
- Jemal, A.¹ Bray, F.² Center, M.M.³ Ferlay, J.⁴ Ward, E.⁵ Forman, D.⁶

2
- 77954332103
- Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- O.b.o.t.E.G.W. Group
- L. Crinò, W. Weder, J. van Meerbeeck, E. Felip O.b.o.t.E.G.W. Group Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann. Oncol. 21 2010 v103 v115
- (2010) Ann. Oncol. , vol.21
- Crinò, L.¹ Weder, W.² Van Meerbeeck, J.³ Felip, E.⁴

3
- 77956178360
- EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer
- A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
- (2010) Oncogene , vol.29 , pp. 4741-4751
- Singh, A.¹ Settleman, J.²

4
- 78449255989
- MiR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and β-catenin signaling
- H. Xia, W.K. Cheung, J. Sze, G. Lu, S. Jiang, H. Yao, X.-W. Bian, W.S. Poon, H.-F. Kung, and M.C. Lin miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and β-catenin signaling J. Biol. Chem. 285 2010 36995 37004
- (2010) J. Biol. Chem. , vol.285 , pp. 36995-37004
- Xia, H.¹ Cheung, W.K.² Sze, J.³ Lu, G.⁴ Jiang, S.⁵ Yao, H.⁶ Bian, X.-W.⁷ Poon, W.S.⁸ Kung, H.-F.⁹ Lin, M.C.¹⁰

5
- 34548411746
- TGF-β-induced EMT: Mechanisms and implications for fibrotic lung disease
- B.C. Willis, and Z. Borok TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease Am. J. Physiol. Lung Cell. Mol. Physiol. 293 2007 L525 L534
- (2007) Am. J. Physiol. Lung Cell. Mol. Physiol. , vol.293
- Willis, B.C.¹ Borok, Z.²

6
- 84870270903
- SPARC expression and prognostic value in non-small cell lung cancer
- Y. Huang, J. Zhang, Y. Zhao, W. Jiang, C. Xue, F. Xu, H. Zhao, Y. Zhang, L. Zhao, and Z. Hu SPARC expression and prognostic value in non-small cell lung cancer Chin. J. Cancer 31 2012 541 548
- (2012) Chin. J. Cancer , vol.31 , pp. 541-548
- Huang, Y.¹ Zhang, J.² Zhao, Y.³ Jiang, W.⁴ Xue, C.⁵ Xu, F.⁶ Zhao, H.⁷ Zhang, Y.⁸ Zhao, L.⁹ Hu, Z.¹⁰

7
- 33646594731
- Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization
- C. Colin, N. Baeza, C. Bartoli, F. Fina, N. Eudes, I. Nanni, P. Martin, L. Ouafik, and D. Figarella-Branger Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization Oncogene 25 2005 2818 2826
- (2005) Oncogene , vol.25 , pp. 2818-2826
- Colin, C.¹ Baeza, N.² Bartoli, C.³ Fina, F.⁴ Eudes, N.⁵ Nanni, I.⁶ Martin, P.⁷ Ouafik, L.⁸ Figarella-Branger, D.⁹

8
- 84887103172
- SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice
- Y. Li, L. Chen, T.H.M. Chan, M. Liu, K.-L. Kong, J.-L. Qiu, Y.-F. Yuan, and X.-Y. Guan SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice Gastroenterology 2012
- (2012) Gastroenterology
- Li, Y.¹ Chen, L.² Chan, T.H.M.³ Liu, M.⁴ Kong, K.-L.⁵ Qiu, J.-L.⁶ Yuan, Y.-F.⁷ Guan, X.-Y.⁸

9
- 36849069941
- Downregulation of several fibulin genes in prostate cancer
- A. Wlazlinski, R. Engers, M.J. Hoffmann, C. Hader, V. Jung, M. Müller, and W.A. Schulz Downregulation of several fibulin genes in prostate cancer Prostate 67 2007 1770 1780
- (2007) Prostate , vol.67 , pp. 1770-1780
- Wlazlinski, A.¹ Engers, R.² Hoffmann, M.J.³ Hader, C.⁴ Jung, V.⁵ Müller, M.⁶ Schulz, W.A.⁷

10
- 84876670147
- Testican-3: A brain-specific proteoglycan member of the BM-40/SPARC/osteonectin family
- U. Hartmann, H. Hülsmann, J. Seul, S. Röll, H. Midani, I. Breloy, D. Hechler, R. Müller, and M. Paulsson Testican-3: a brain-specific proteoglycan member of the BM-40/SPARC/osteonectin family J. Neurochem. 2013
- (2013) J. Neurochem.
- Hartmann, U.¹ Hülsmann, H.² Seul, J.³ Röll, S.⁴ Midani, H.⁵ Breloy, I.⁶ Hechler, D.⁷ Müller, R.⁸ Paulsson, M.⁹

11
- 7744235531
- Testican-1, an inhibitor of pro-MMP-2 activation, is expressed in cartilage
- H.-J. Hausser, R. Decking, and R.E. Brenner Testican-1, an inhibitor of pro-MMP-2 activation, is expressed in cartilage Osteoarthritis Cartilage 12 2004 870 877
- (2004) Osteoarthritis Cartilage , vol.12 , pp. 870-877
- Hausser, H.-J.¹ Decking, R.² Brenner, R.E.³

12
- 0034213938
- Regulated expression of the proteoglycan SPOCK in the neuromuscular system
- C. Cifuentes-Diaz, P.M. Alliel, F. Charbonnier, S. De La Porte, J. Molgó, D. Goudou, F. Rieger, and J.-P. Périn Regulated expression of the proteoglycan SPOCK in the neuromuscular system Mech. Dev. 94 2000 277 282
- (2000) Mech. Dev. , vol.94 , pp. 277-282
- Cifuentes-Diaz, C.¹ Alliel, P.M.² Charbonnier, F.³ De La Porte, S.⁴ Molgó, J.⁵ Goudou, D.⁶ Rieger, F.⁷ Périn, J.-P.⁸

13
- 79953147370
- A perspective on cancer cell metastasis
- C.L. Chaffer, and R.A. Weinberg A perspective on cancer cell metastasis Science 331 2011 1559 1564
- (2011) Science , vol.331 , pp. 1559-1564
- Chaffer, C.L.¹ Weinberg, R.A.²

14
- 23344434132
- Progress in molecular mechanisms of tumor metastasis and angiogenesis
- A. Harlozinska Progress in molecular mechanisms of tumor metastasis and angiogenesis Anticancer Res. 25 2005 3327 3333
- (2005) Anticancer Res. , vol.25 , pp. 3327-3333
- Harlozinska, A.¹

15
- 84881028557
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- H. Xia, L.L.P.J. Ooi, and K.M. Hui MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer Hepatology 2013
- (2013) Hepatology
- Xia, H.¹ Ooi, L.L.P.J.² Hui, K.M.³

16
- 84867740278
- MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics
- H. Xia, and K.M. Hui MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics Cancer Gene Ther. 19 2012 723 730
- (2012) Cancer Gene Ther. , vol.19 , pp. 723-730
- Xia, H.¹ Hui, K.M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.